Alterity Therapeutics Files 6-K on Security Cessation
Ticker: PRNAF · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: securities-law, filing-update
Related Tickers: ATH
TL;DR
ATH securities cessation notice filed. Check your holdings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on June 30, 2025, reporting a notification of cessation of securities for ATH. This filing is incorporated by reference into several of their existing SEC registration statements, including Form S-8 and Form F-3 filings.
Why It Matters
This filing indicates a change in the company's securities status, which could impact investors' holdings or trading activities.
Risk Assessment
Risk Level: medium — Cessation of securities can indicate significant corporate actions or financial distress, requiring investor attention.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ATH (company) — Security identifier
- June 30, 2025 (date) — Filing date
- Form S-8 (document) — Incorporated by reference
- Form F-3 (document) — Incorporated by reference
FAQ
What is the specific reason for the cessation of ATH securities?
The filing is a 'Notification of cessation of securities' for ATH, but the specific reason is not detailed within the provided text.
When was this Form 6-K filed?
The Form 6-K was filed on June 30, 2025.
Which SEC registration statements does this 6-K filing get incorporated into?
This Form 6-K is incorporated into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What was Alterity Therapeutics Limited's former name?
Alterity Therapeutics Limited's former name was PRANA BIOTECHNOLOGY LTD.
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).